Related Experiment Video
Updated: Jan 15, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Current Advances in Nanocarriers for Cancer Therapy
Reza Zeinali1, Davood Zaeifi2, S Yasaman Zolfaghari-Moghaddam3
1Group of Molecular and Industrial Biotechnology, Department of Chemical Engineering, Universität Politècnica de Catalunya, Terrassa, Spain.
None:
Nanocarriers have shown optimal therapeutic outcomes through their great potential for encapsulating and effectively delivering bioactive compounds into target cells by navigating a series of intracellular barriers. In this review, drug resistance and cell barriers impeding the drug delivery process have been discussed. Besides, the efficiency of nanocarriers, along with recent advances and novel strategies to overcome drug resistance, increase cell internalization, promote intracellular trafficking, target subcellular locations, and control drug release, has been reviewed. Different types of nanocarriers from the viewpoint of cancer treatment have been introduced, and their prospect as drug delivery vehicles for cancer therapy have been visualized. Hence, this review may contribute to developing nanocarriers for effective and precise drug delivery to a wide range of cells and intracellular targets.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy

